The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly outlines recommendations for postexposure chemoprophylaxis following invasive meningococcal disease, which is caused by Neisseria meningitidis. This organism is transmitted through direct contact with respiratory secretions or saliva, such as through kissing, sharing eating utensils, or prolonged close household contact.
Household members are considered high-risk close contacts because they have sustained, close exposure to the patient’s respiratory droplets and oral secretions. As a result, they should receive chemoprophylaxis as soon as possible, ideally within 24 hours of identification of the index case, to prevent secondary cases. This recommendation applies regardless of vaccination status.
The other options do not meet criteria for prophylaxis. Healthcare personnel exposed only to urine or feces (Option B) are not at risk, as N. meningitidis is not transmitted via these routes. Casual school contact or sharing supplies (Option C) does not constitute close exposure to respiratory secretions. Athletic teammates (Option D) generally do not require prophylaxis unless there was direct exposure to saliva (e.g., sharing water bottles or mouthguards).
For CIC exam preparation, it is essential to recognize that chemoprophylaxis is limited to close contacts with direct exposure to respiratory secretions, with household members being the most consistent and clearly defined group requiring prophylaxis.

Surveillance is a critical tool in infection prevention and control, used to monitor disease trends and guide public health responses. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the “Surveillance and Epidemiologic Investigation” domain, which aligns withthe Centers for Disease Control and Prevention (CDC) “Principles of Epidemiology in Public Health Practice” (3rd Edition, 2012). The question describes a process of collecting and analyzing indicators to signal an increase in community illness, requiring identification of the appropriate surveillance type among the options provided.
Option C, “Syndromic,” is the correct answer. Syndromic surveillance involves monitoring non-specific health indicators or symptoms (e.g., fever, respiratory complaints, or gastrointestinal issues) that may precede a formal diagnosis, aiming to detect potential outbreaks or increases in community illness early. The CDC defines syndromic surveillance as the real-time or near-real-time collection, analysis, and interpretation of health-related data to provide actionable information, often in collaboration with public health agencies. This approach uses data from sources like emergency department visits, over-the-counter medication sales, or absenteeism reports to identify trends before laboratory confirmation, making it well-suited to the described scenario of signaling community illness increases.
Option A, “Passive,” involves healthcare providers or laboratories reporting cases to public health authorities on a voluntary or mandatory basis without active prompting (e.g., routine notifiable disease reporting). While passive surveillance contributes to baseline data, it is less proactive and not specifically designed to signal early increases in illness, making it less fitting. Option B, “Active,” entails public health officials actively seeking data from healthcare facilities or providers (e.g., calling to confirm cases during an outbreak). This is more resource-intensive and typically used for specific investigations rather than ongoing community trend monitoring, which aligns better with syndromic methods. Option D, “Targeted,” refers to surveillance focused on a specific population, disease, or event (e.g., monitoring TB in a high-risk group). The scenario’s broad focus on community illness indicators does not suggest a targeted approach.
The CBIC Practice Analysis (2022) and CDC guidelines highlight syndromic surveillance as a key strategy for early detection of community-wide health threats, often involving collaboration with public health agencies. Option C best matches the described activity of analyzing indicators to signal illness increases, making it the correct choice.
References:
CBIC Practice Analysis, 2022.
CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.
CDC Syndromic Surveillance Systems, 2020.

The Certification Study Guide (6th edition) stresses that infection prevention leaders must understand basic workforce and FTE calculations to ensure appropriate staffing and compliance with approved resource allocations. An FTE is defined as 40 hours worked per week, and part-time hours must be converted proportionally.
First, calculate the FTEs already in use:
* Director: 40 hours/week ÷ 40 = 1.0 FTE
* Infection preventionist: 32 hours/week ÷ 40 = 0.8 FTE
* Infection preventionist: 16 hours/week ÷ 40 = 0.4 FTE
* Secretarial support: 40 hours/week ÷ 40 = 1.0 FTE
Total current FTEs:
1.0 + 0.8 + 0.4 + 1.0 = 3.2 FTEs
The approved staffing total is 3.8 FTEs. To determine how many additional FTEs may be hired, subtract current FTE usage from the approved total:
3.8 # 3.2 = 0.6 FTE
Therefore, the director may hire 0.6 additional FTE, which could be fulfilled by a part-time infection preventionist or split among staff roles, depending on organizational needs.
CIC exam questions frequently test practical management skills, including staffing calculations, budgeting awareness, and resource allocation. Accurate FTE calculations ensure compliance with administrative approvals and support safe, effective infection prevention program operations.
Reference: Certification Study Guide (CBIC/CIC Exam Study Guide), 6th edition, Chapter 7: Management and Communication.
========

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that Aspergillus infections associated with healthcare settings are most commonly environmentally acquired, particularly during construction, renovation, or demolition activities. Aspergillus fumigatus is an airborne mold, and transmission occurs through inhalation of spores, not via person-to-person contact.
In this scenario, the infection preventionist should focus on air handling systems and environmental controls, which makes options A, B, and D critical questions. Ensuring that ventilation filters are appropriately maintained (Option A) and evaluating the proximity of air-intake units to construction activities (Option B) are essential elements of an Infection Control Risk Assessment (ICRA). Asking whether Aspergillus was present before construction (Option D) helps determine whether this represents a construction-associated cluster rather than baseline colonization.
Option C is the least relevant because healthcare personnel do not transmit Aspergillus between patients.
Unlike organisms spread via contact or droplets, Aspergillus spores are ubiquitous in dust and air and are introduced through environmental disruption. Therefore, evaluating shared staff assignments does not contribute meaningfully to identifying the source of exposure.
For CIC exam preparation, it is critical to remember that construction-associated aspergillosis investigations focus on air quality, ventilation, and environmental controls-not staff transmission pathways.

The scenario describes an outbreak of Aspergillus infections among three patients on an oncology unit following recent renovations, with the infections suspected to be facility-acquired. Aspergillus is a mold commonly associated with environmental sources, particularly airborne spores, and its presence in immunocompromised patients (e.g., oncology patients) poses a significant risk. The infection preventionist must identify the appropriate environmental microbiological monitoring strategy, guided by the Certification Board of Infection Control and Epidemiology (CBIC) and CDC recommendations. Let’s evaluate each option:
* A. Air: Aspergillus species are ubiquitous molds that thrive in soil, decaying vegetation, and construction dust, and they are primarily transmitted via airborne spores. Renovations can disturb these spores, leading to aerosolization and inhalation by vulnerable patients. Culturing the air using methods such as settle plates, air samplers, or high-efficiency particulate air (HEPA) filtration monitoring is a standard practice to detect Aspergillus during construction or post-renovation in healthcare settings, especially oncology units where patients are at high risk for invasive aspergillosis. This aligns with CBIC’s emphasis on environmental monitoring for airborne pathogens, making it the most appropriate choice.
* B. Ice: Ice can be a source of contamination with bacteria (e.g., Pseudomonas, Legionella) or other pathogens if improperly handled or stored, but it is not a typical reservoir for Aspergillus, which is a mold requiring organic material and moisture for growth. While ice safety is important in infection control, culturing ice is irrelevant to an Aspergillus outbreak linked to renovations and is not a priority in this context.
* C. Carpet: Carpets can harbor dust, mold, and other microorganisms, especially in high-traffic or poorly maintained areas. Aspergillus spores could theoretically settle in carpet during renovations, but carpets are not a primary source of airborne transmission unless disturbed (e.g., vacuuming). Culturing carpet might be a secondary step if air sampling indicates widespread contamination, but it is less direct and less commonly recommended as the initial monitoring site compared to air sampling.
* D. Aerators: Aerators (e.g., faucet aerators) can harbor waterborne pathogens like Pseudomonas or Legionella due to biofilm formation, but Aspergillus is not typically associated with water systems unless there is significant organic contamination or aerosolization from water sources (e.g., cooling towers). Culturing aerators is relevant for waterborne outbreaks, not for an Aspergillus outbreak linked to renovations, making this option inappropriate.
The best answer is A, culturing the air, as Aspergillus is an airborne pathogen, and renovations are a known risk factor for spore dispersal in healthcare settings. This monitoring strategy allows the infection preventionist to confirm the source, assess the extent of contamination, and implement control measures (e.g., enhanced filtration, construction barriers) to protect patients. This is consistent with CBIC and CDC guidelines for managing fungal outbreaks in high-risk units.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which recommends air sampling for Aspergillus during construction-related outbreaks.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes environmental monitoring for facility-acquired infections.
CDC Guidelines for Environmental Infection Control in Healthcare Facilities (2022), which advocate air culturing to detect Aspergillus post-renovation in immunocompromised patient areas.

Comprehensive and Detailed In-Depth Explanation:
Hand hygiene remains the single most effective intervention to prevent the spread of vancomycin-resistant Enterococcus (VRE) in healthcare settings. Implementing an audit and feedback system significantly improves compliance and reduces VRE transmission.
Step-by-Step Justification:
* Hand Hygiene Compliance Audit and Feedback (Best Strategy)
* Studies show that poor hand hygiene is the primary mode of VRE transmission in hospitals.
* Implementing real-time auditing with feedback ensures sustained compliance and helps identify weak areas.
* Why Other Options Are Incorrect:
* A. Screening all patients and isolating VRE-positive patients:
* While screening helps identify carriers, contact precautions alone are not sufficient without strong hand hygiene enforcement.
* B. Restricting vancomycin use:
* While antimicrobial stewardship is crucial, vancomycin use alone does not drive VRE outbreaks-poor infection control practices do.
* D. Conducting environmental sampling weekly:
* Routine sampling is not necessary; immediate terminal disinfection and improved hand hygiene are more effective.
CBIC Infection Control References:
* APIC Text, “VRE Prevention and Hand Hygiene,” Chapter 11.
* APIC-JCR Workbook, “Antimicrobial Resistance and Infection Control Measures,” Chapter 7.

The pneumococcal vaccine is designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for diseases such as pneumonia, meningitis, and bacteremia. The appropriateness of this vaccine depends on the population’s risk profile, particularly their susceptibility to invasive pneumococcal disease (IPD). The Certification Board of Infection Control and Epidemiology (CBIC) highlights the role of infection preventionists as educators in promoting vaccination as a key risk reduction strategy, aligning with the “Education and Training” domain (CBIC Practice Analysis, 2022). The Centers for Disease Control and Prevention (CDC) provides specific guidelines on pneumococcal vaccination, recommending it for individuals at higher risk due to underlying medical conditions or immunologic status.
Option A, asplenic patients, refers to individuals who have had their spleen removed (e.g., due to trauma or disease) or have a nonfunctional spleen (e.g., in sickle cell disease). The spleen plays a critical role in clearing encapsulated bacteria like Streptococcus pneumoniae from the bloodstream. Without a functioning spleen, these patients are at significantly increased risk of overwhelming post-splenectomy infection (OPSI), with pneumococcal disease being a leading cause. The CDC and Advisory Committee on Immunization Practices (ACIP) strongly recommend pneumococcal vaccination, including both PCV15/PCV20 and PPSV23, for asplenic patients, making this group the most appropriate for the vaccine in this context. The infection preventionist should prioritize educating these patients and their families about the vaccine’s importance and timing.
Option B, international travelers, may benefit from various vaccines depending on their destination (e.g., yellow fever or typhoid), but pneumococcal vaccination is not routinely recommended unless they have specific risk factors (e.g., asplenia or chronic illness) or are traveling to areas with high pneumococcal disease prevalence. This group is not inherently a priority for pneumococcal vaccination. Option C, immunocompromised newborns, includes infants with congenital immunodeficiencies or other conditions, who may indeed require pneumococcal vaccination as part of their routine immunization schedule (e.g., PCV15 or PCV20 starting at 2 months). However, newborns are generally covered under universal childhood vaccination programs, and the question’s focus on “MOST appropriate” suggests a group with a more specific, elevated risk, which asplenic patients fulfill. Option D, patients in behavioral health settings, may have varied health statuses, but this group is not specifically targeted for pneumococcal vaccination unless they have additional risk factors (e.g., chronic diseases), making it less appropriate than asplenic patients.
The CBIC emphasizes tailoring education to high-risk populations, and the CDC’s Adult and Pediatric Immunization Schedules (2023) identify asplenic individuals as a top priority for pneumococcal vaccination due to their extreme vulnerability. Thus, the infection preventionist should focus on asplenic patients as the group for whom the pneumococcal vaccine is most appropriate.
References:
* CBIC Practice Analysis, 2022.
* CDC Adult Immunization Schedule, 2023.
* CDC Pediatric Immunization Schedule, 2023.
* ACIP Recommendations for Pneumococcal Vaccination, 2022.

The optimal specimen for identifying the etiologic agent in a prosthetic joint infection (PJI) is a joint aspirate (synovial fluid). This is because:
* It provides direct access to the infected site without contamination from external sources.
* It allows for accurate microbiologic culture, Gram stain, and leukocyte count analysis.
Why the Other Options Are Incorrect?
* A. Blood – Blood cultures may help detect hematogenous spread but are not the best sample for identifying localized prosthetic joint infections.
* B. Wound drainage – Wound cultures often contain contaminants from surrounding skin flora and do not accurately reflect joint space infection.
* D. Sinus tract tissue – Cultures from sinus tracts often represent colonization rather than the primary infecting organism.
CBIC Infection Control Reference
APIC guidelines confirm that joint aspirate is the most reliable specimen for diagnosing prosthetic joint infections.

A patient with active shingles (herpes zoster) is contagious to individuals who have never had varicella (chickenpox) or the varicella vaccine. The best roommate selection is someone who has received the varicella vaccine, as they are considered immune and not at risk for contracting the virus.
Why the Other Options Are Incorrect?
* B. Treatment with acyclovir – Acyclovir treats herpes zoster but does not prevent transmission to others.
* C. A history of herpes simplex – Prior herpes simplex virus (HSV) infection does not confer immunity to varicella-zoster virus (VZV).
* D. Varicella zoster immunoglobulin (VZIG) – VZIG provides temporary immunity but does not offer long-term protection like the vaccine.
CBIC Infection Control Reference
APIC guidelines recommend placing patients with active shingles in a room with individuals immune to varicella, such as those vaccinated.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most important criterion when selecting a disinfectant is the intended purpose for which it will be used. Disinfectants must be chosen based on the type of surface or item, the level of microbial kill required, and the risk of infection associated with the use of that item. This approach aligns with Spaulding’s classification system, which categorizes items as critical, semi-critical, or noncritical and guides the required level of disinfection or sterilization.
Understanding the purpose of the disinfectant ensures that the selected product is effective against the appropriate microorganisms and suitable for the clinical application, whether it involves environmental surfaces, noncritical patient care equipment, or semi-critical devices. For example, a low-level disinfectant may be sufficient for noncritical items, whereas high-level disinfection is required for semi-critical devices.
Selecting a disinfectant without first defining its purpose can result in ineffective infection prevention or unnecessary exposure to harsh chemicals.
Option A is incorrect because disinfectants are not intended for use on living tissue; antiseptics serve that role.
Option C is secondary-while active ingredients matter, they are evaluated after determining intended use.
Option D is important for safety and regulatory compliance but does not drive appropriateness of clinical application.
For the CIC exam, recognizing that intended use is the foundational decision point in disinfectant selection is essential for evidence-based infection prevention practice.

Ventilator-associated events (VAEs) are complications that occur in patients receiving mechanical ventilation and include conditions such as ventilator-associated pneumonia (VAP), pulmonary edema, and atelectasis.
The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that patient positioning plays a critical role in preventing aspiration and subsequent respiratory complications in mechanically ventilated patients.
Maintaining patients in a supine position, particularly during transport, increases the risk of aspiration of gastric contents and oropharyngeal secretions. Aspiration is a well-recognized contributing factor to the development of VAEs because it can lead to infection, inflammation, and worsening oxygenation. The Study Guide recommends maintaining the head of the bed elevated (generally 30-45 degrees) whenever feasible, including during care activities and transport, to reduce aspiration risk.
The other options listed-daily sedation vacation, daily weaning assessment, and daily oral care with chlorhexidine-are evidence-based prevention strategies that are part of ventilator care bundles. These interventions are designed to reduce the duration of mechanical ventilation, improve pulmonary function, and decrease microbial colonization, all of which lower the risk of VAEs rather than contribute to them.
Therefore, supine positioning during transport is the most likely factor contributing to an increase in ventilator-associated events and represents a deviation from recommended infection prevention practices.

ForSarcoptes scabiei(scabies),Contact Precautionsshould remainin place until 24 hours after effective treatment has been completed. The first-line treatment is5% permethrin cream, which is applied to the entire body and left on for8-14 hoursbefore being washed off.
Why the Other Options Are Incorrect?
* A. When the treatment cream is applied- Themite is still presentand infectiousuntil treatment has fully taken effect.
* B. When the bed linen is changed-While changing linens is necessary, it doesnot indicate that the infestation has cleared.
* D. 24 hours after the second treatment- Mostcases require only one treatmentwith permethrin, though severe cases may need a second dose after a week.
CBIC Infection Control Reference
According toAPIC guidelines,Contact Precautions can be discontinued 24 hours after effective treatment has been administered.

The proper use of chemical disinfectants is a critical aspect of infection control, as outlined by the Certification Board of Infection Control and Epidemiology (CBIC). Chemical disinfectants are used to eliminate or reduce pathogenic microorganisms on inanimate objects, and their effective application requires adherence to specific protocols to ensure safety and efficacy. Let’s evaluate each option based on infection control standards:
* A. All items to be processed must be cleaned prior to being submerged in solution.: This statement is a fundamental principle of disinfectant use. Cleaning (e.g., removing organic material such as blood, tissue, or dirt) is a prerequisite before disinfection because organic matter can inactivate or reduce the effectiveness of chemical disinfectants. The CBIC emphasizes that proper cleaning is the first step in the disinfection process to ensure that disinfectants can reach and kill microorganisms. This step is universally required for all levels of disinfection (low, intermediate, and high), making it a characterizing feature of proper use.
* B. The label on the solution being used must indicate that it kills all viable micro-organisms.: This statement is misleading. No disinfectant can be guaranteed to kill 100% ofall viable microorganisms under all conditions, as efficacy depends on factors like contact time, concentration, and the presence of organic material. Disinfectant labels typically indicate the types of microorganisms (e.g., bacteria, viruses, fungi) and the level of disinfection (e.g., high-level, intermediate-level) they are effective against, based on standardized tests (e.g., EPA or FDA guidelines). Claiming that a solution kills all viable microorganisms is unrealistic and not a requirement for proper use; instead, the label must specify the intended use and efficacy, which varies by product.
* C. The solution should be adaptable for use as an antiseptic.: An antiseptic is a chemical agent used on living tissue (e.g., skin) to reduce microbial load, whereas a disinfectant is used on inanimate surfaces.
While some chemicals (e.g., alcohol) can serve both purposes, this is not a requirement for proper disinfectant use. The adaptability of a solution for antiseptic use is irrelevant to its classification or application as a disinfectant, which focuses on environmental or equipment decontamination. This statement does not characterize proper disinfectant use.
* D. A chemical indicator must be used with items undergoing high-level disinfection.: Chemical indicators (e.g., test strips or tapes) are used to verify that the disinfection process has met certain parameters (e.g., concentration or exposure time), particularly in sterilization or high-level disinfection (HLD). While this is a recommended practice for quality assurance in HLD (e.g., with glutaraldehyde or hydrogen peroxide), it is not a universal requirement for all chemical disinfectant use. HLD applies specifically to semi-critical items (e.g., endoscopes), and the need for indicators depends on the protocol and facility standards. This statement is too narrow and specific to characterize the proper use of chemical disinfectants broadly.
The correct answer is A, as cleaning prior to disinfection is a foundational and universally applicable step in the proper use of chemical disinfectants. This aligns with CBIC guidelines, which stress the importance of a clean surface to maximize disinfectant efficacy and prevent infection transmission in healthcare settings.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which mandates cleaning as a prerequisite for effective disinfection.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes protocols for the proper use of disinfectants, emphasizing pre-cleaning.
CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities (2021), which reinforce that cleaning must precede disinfection to ensure efficacy.

* Maintaining hot water at 140°F (60C) prevents Legionella growth and is the most effective control strategy.
* Flushing water (A) alone is not sufficient.
* Carbon filters (C) do not remove Legionella.
* Routine testing (D) is not always necessary unless an outbreak occurs.
CBIC Infection Control References:
* APIC Text, “Waterborne Pathogens and Infection Control,” Chapter 9.

The CBIC Certified Infection Control Exam Study Guide (6th edition) explains that the effectiveness of disinfection depends on multiple physical, chemical, and biologic factors, but virulence of the organism is not one of them. Virulence refers to an organism’s ability to cause disease in a host, which is a clinical characteristic, not a determinant of susceptibility to disinfectants.
Disinfection efficacy is influenced by factors such as the type and number of microorganisms, particularly their intrinsic resistance (for example, spores are more resistant than vegetative bacteria), making option C a true determinant. The amount of organic material present (option B) is also critical, as organic matter can inactivate disinfectants or shield microorganisms from exposure. Likewise, the length of exposure (contact time) to the chemical agent (option D) is essential to achieving the desired level of microbial kill and is specified in manufacturer instructions for use.
Virulence does not affect how easily an organism is destroyed by a disinfectant. For example, a highly virulent organism may be easily killed by a low-level disinfectant, while a less virulent organism such as a bacterial spore may be highly resistant. Therefore, virulence plays no role in determining disinfection effectiveness.
For CIC exam preparation, it is important to distinguish between clinical severity and microbial resistance.
Disinfection effectiveness is based on resistance characteristics and process variables-not on how dangerous the organism is to humans.

To determine the number of employees who seroconverted (became infected) after a needlestick exposure, we use the given data:
* Total Needlestick Injuries: 250
* Needlestick Injuries Involving Bloodborne Pathogens: 100
* Seroconversion Rate: 2%
Calculation:
A black text with black numbers AI-generated content may be incorrect.

Why Other Options Are Incorrect:
* A. 1: Incorrect calculation; 2% of 100 is 2, not 1.
* C. 5: Overestimates the actual number of infections.
* D. 10: Exceeds the calculated value based on given data.
CBIC Infection Control References:
* APIC Text, “Occupational Exposure and Seroconversion Risks”.
* APIC Text, “Bloodborne Pathogens and Needlestick Injury Prevention”

The correct answer is B, “The rate may be higher if the denominator is very small,” as this provides the most plausible explanation for the observed data in the annual report. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the CAUTI rate is calculated as the number of CAUTIs per 1,000 catheter days, where catheter days serve as the denominator. The report indicates a dramatic decrease in urinary catheter days and a slight decrease in the number of CAUTIs, yet the overall CAUTI rate has not increased. This discrepancy can occur if the denominator (catheter days) becomes very small, which can inflate or destabilize the rate, potentially masking an actual increase in the infection risk per catheter day (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.2 – Analyze surveillance data). A smaller denominator amplifies the impact of even a slight change in the number of infections, suggesting that the rate may be higher than expected or less reliable, necessitating further investigation.
Option A (the rate is incorrect and needs to be recalculated) assumes an error in the calculation without evidence, which is less specific than the denominator effect explanation. Option C (the rate is not affected by the number of catheter days) is incorrect because the CAUTI rate is directly influenced by the number of catheter days as the denominator; a decrease in catheter days should typically lower the rate if infections decrease proportionally, but the lack of an increase here suggests a calculation or interpretation issue. Option D (decreasing catheter days will not have an effect on decreasing CAUTI) contradicts evidence-based practice, as reducing catheter days is a proven strategy to lower CAUTI incidence, though the rate’s stability here indicates a potential statistical artifact.
The explanation focusing on the denominator aligns with CBIC’s emphasis on accurate surveillance and data analysis to guide infection prevention strategies, allowing the infection preventionist to advise administration on the need to review data trends or adjust monitoring methods (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies). This insight can prompt a deeper analysis to ensure the CAUTI rate reflects true infection risk.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.2 – Analyze surveillance data, 2.5 – Use data to guide infection prevention and control strategies.

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies inadequate hand hygiene as the most common and significant factor associated with healthcare-associated transmission of methicillin- resistant Staphylococcus aureus (MRSA). MRSA is primarily transmitted via direct contact, most often through the hands of healthcare personnel after contact with colonized or infected patients or contaminated environmental surfaces.
While MRSA-infected or colonized patients serve as reservoirs for the organism, transmission does not occur unless there is a breakdown in infection prevention practices, particularly hand hygiene. Numerous studies and surveillance findings cited in the Study Guide demonstrate that adherence to hand hygiene protocols- before and after patient contact, after contact with bodily fluids, and after contact with the patient environment-is the single most effective measure to reduce MRSA spread within healthcare facilities.
Improper ventilation (Option A) is associated with airborne pathogens, not MRSA, which is not transmitted via the airborne route. MRSA-colonized healthcare workers (Option D) are far less commonly implicated in transmission than transient hand contamination, and routine screening of staff is not recommended except during specific outbreak investigations. Option B describes a reservoir, not the primary mechanism of transmission.
For CIC exam purposes, this question reinforces a foundational principle of infection prevention: failure to perform appropriate hand hygiene is the leading cause of healthcare-associated MRSA transmission, making it the correct and best answer.